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Bacterial Cell Factories 
Applying thermophiles to fuel the biobased economy 
Esteemed Rector Magnificus, dear colleagues, family and friends. A warm welcome to all of you.
In this inaugural lecture I will introduce you to the fascinating world of bacterial cell 
factories and explain their relevance for the biobased economy. 
Bacteria are single-cellular organisms. There are many different species that all have 
their own characteristics. Some can be used in industrial applications. Like factories, 
bacteria can convert feedstocks into useful products. Therefore, we can consider them 
as tiny factories on their own, or bacterial cell factories.
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Figure 1. Biobased versus Oil-based economy
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Bacterial cell factories and the biobased economy 
Another term that needs introduction is the biobased economy. This refers to all 
economic activity based on raw materials of biological origin. Since the middle of the 
20th century, many chemical products we use are derived from petroleum. This linear 
use of carbon takes petrochemical feedstocks from the earth, which, after a short 
period of use, end up as carbon dioxide in the atmosphere. The more sustainable 
biobased economy has chemicals produced from renewable resources. Carbon 
dioxide and water are converted to sugars by plants. These can be converted to green 
chemicals by fermentation with bacterial cell factories. These green chemicals are 
used for their respective applications and if they can no longer be used, or re-used, 
they can be converted back to carbon dioxide forming a closed loop. The need to shift 
from an oil-based economy to a biobased economy is becoming more and more 
evident. Last year’s Paris Agreement aims to combat climate change and accelerate 
and intensify the actions and investments needed for a sustainable low-carbon future. 
The Dutch government translated this in the ambition to establish a circular economy 
before 2050 and to reduce the use of primary raw materials, including petrol-based 
ones, with 50% before 2030. It defined a dedicated program to realize this (Dijksma & 
Kamp, 2016). The re-use of materials is the central theme of the circular economy: 
waste does not exist. In addition, production of chemicals from renewable feedstocks 
is an integral part of this vision. The anticipated growth of the biobased economy will 
be largely dependent on the technological advancements in the years to come.
Before I will elaborate on what advancements I foresee for industrial strain 
development, I would like to spend a few words on its history. Originally, bacteria 
were used how they were isolated. Over the last decades, development of metabolic 
engineering technologies have enabled specific fine-tuning of these bacteria to 
optimize their productivity or, even one step further, to divert their metabolism to 
have them produce non-natural products. 
Industrial fermentation
Industrial fermentation for production of chemicals outdates their production from 
petroleum. Fermentation of food products has a history of over thousands of years. 
Lactic acid fermentation was the first industrial fermentation process for production 
of a pure chemical. The French scientist Edmond Frémy reported in 1841 a process 
for large-scale production of lactic acid from fermentation of milk. At the time, the 
role of bacteria was not yet identified. It was Louis Pasteur who in 1858 described the 
lactic “yeast”. In 1881 Charles Avery filed a United States patent on an improved 
process for the manufacture of lactates by fermentation using a lactic ferment. A few 
years later Avery opened the first industrial lactate fermentation plant in Littleton 
(Benninga, 1990). Around the same time Carl Wehmer discovered fermentation of 
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citric acid by two species of fungi. He developed the industrial process that resulted 
in the first amounts of fermentative citric acid in the Alsace in 1893 (Benninga, 1990).
Another fermentation process with a long history is the acetone-butanol-ethanol 
fermentation, abbreviated ABE. This fermentation uses Clostridium acetobutylicum. 
The process was developed by the chemist Weizmann, who later became the first 
president of Israel. The production of explosives in England during World War I 
gave rise to a high demand for acetone as solvent. In 1916 the Weizmann process was 
used to start-up industrial-scale ABE fermentation (Moon et al., 2016). The years 
after, it became the second largest fermentation process next to ethanol. The ABE 
fermentation declined in the 1950s as a result of the rapid advances in petrochemical 
industry. Lately, there has been renewed interest in bio-butanol production by 
fermentation from several industrial parties.
From metabolic engineering to synthetic biology
Advances in molecular biology tool development allowed for design and 
construction of industrial production strains through metabolic engineering. The  
best studied bacterium, Escherichia coli has been the organism of choice for many 
advanced engineering studies. I will give three examples of increasing level of 
engineering complexity to generate industrial production strains from E. coli. 
Central metabolism 
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Figure 2. Metabolic engineering of E. coli for production of d-lactic acid from 
glucose (Zhou et al., 2006). Source E. coli electron microscopy picture: 
Wadsworth.org.
6 | Prof.dr Richard van Kranenburg   Bacterial Cell Factories 
The first example is construction of a strain for production of d-lactic acid. This 
chemical can be used to produce chiral molecules in, for instance, the agrochemical 
industry. In addition, it can be polymerized to poly-lactic acid (PLA) that can be used 
to produce bioplastics. Natural E. coli strains will ferment sugars to a mixture of 
acetate, ethanol, formate, d-lactate and succinate. To obtain a production strain that 
only produces d-lactate, the conversion pathways to the other products need to be 
blocked. This can be done by removing key genes encoding those pathways from the 
E. coli chromosome. By doing so, researchers from the University of Florida 
generated an E. coli strain that only produced d-lactic acid (Zhou et al., 2006).
The second example is the construction of an industrial 1,3-propanediol production 
strain. 1,3-Propanediol is an oil-derived versatile chemical that can be formulated 
into a many industrial products such as polymers for fibers. In nature, 
1,3-propanediol is produced from glycerol under anaerobic conditions by several 
bacteria. In industry the use of glucose or sucrose is preferred over that of glycerol. 
Hence, an ambitious metabolic engineering project was initiated in the 1990s by a 
research team from Genencor in collaboration with DuPont, at the time separate 
companies, to produce 1,3-propanediol from glucose with E. coli (Nakamura & 
Whited, 2003). The envisioned production was from glucose via glycerol to 
1,3-propanediol. As E. coli is a poor glycerol producer and has no intrinsic capacity  
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Figure 3. Metabolic engineering of E. coli for production of 1,3-propanediol 
from glucose (Nakamura & Whited, 2003). Source E. coli electron microscopy 
picture: Wadsworth.org.
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to produce 1,3-propanediol, the strain had to be provided with pathways from  
non-E. coli origin. The glycerol pathway was taken from baker’s yeast Saccharomyces 
cerevisiae. The subsequent two conversion steps from glycerol to 1,3-propanediol 
were taken from Klebsiella pneumoniae. Surprisingly, it turned out that the second step 
of this conversion was best performed by an endogenous E. coli protein of previously 
unknown function and not by the K. pneumoniae enzyme. Further strain development 
was aimed at improving the yield of 1,3-propanediol. This was achieved by 
elimination of E. coli metabolic pathways competing for consumption of glycerol and 
optimization of glucose uptake. Together with some additional modifications, the 
resulting strain outperformed natural strains and is still being used by DuPont for 
industrial production of 1,3-propanediol.
The third example is the most complicated one. With the onset of full genome 
sequencing, genome-scale models became available. The accumulation of 
information allowed for novel combinations of genes to build synthetic pathways. 
Genomatica started as a software company for genome-scale models. Later, it started 
applying its models to design and build new production strains.  
1,4-Butanediol is a large volume oil-derived chemical with applications in plastics 
and fibers. No natural production pathways for its production are known. Therefore, 
production of 1,4-butanediol from glucose in E. coli does not only require 
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Figure 4. Metabolic engineering of E. coli for production of 1,4-butanediol 
from glucose (Burgard et al., 2016). Source E. coli electron microscopy 
picture: Wadsworth.org.
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combination of heterologous enzymes from different origin, but also depends on 
enzyme flexibility to catalyse non-natural conversions of non-native substrates and 
products. This could only be accomplished by an integrated approach including 
metabolic modelling, high-throughput pathway and strain construction, quantitative 
small-scale screening and systems biology (Burgard et al., 2016). The bio-butanediol 
pathway was designed by bioinformatics analyses of enzymes that catalyze 
analogous transformations. High-throughput in-vivo and in-vitro testing was used to 
identify the best combination. Subsequent steps were required to eliminate by-
products, improve the redox balance and increase yield. This also included exchange 
of the first generation of pathway enzymes by faster and more active variants. In the 
end these engineering cycles resulted in a strain that is currently being implemented 
at commercial scale (Burgard et al., 2016).
With these few examples I have illustrated how both natural bacteria and genetically 
modified organisms can be applied as bacterial cell factories for industrial production 
of green chemicals. The recent advances in metabolic engineering technologies allow 
diversification of product portfolio to non-natural products, broadening the potential 
to replace petrol-based products with green variants. Still, most of these efficient 
technologies are restricted to modification of a single bacterial species as production 
organism, E. coli, which is not necessarily the best host for all products and all 
processes.
Feedstocks
Now let me go back to the concept of the bacterial cell factory. Feedstocks are 
converted to useful products. A logical question is what feedstocks to use for the 
biobased economy? Today, most industrial fermentation processes use sucrose or 
glucose as feedstock. The choice between these mainly depends on availability of the 
feedstocks at the geographic location of the production facility. Sucrose is derived 
from sugar beets or from sugarcane. Glucose is derived from starch, which is either 
corn-starch or tapioca starch. Although these are efficient feedstocks, they are just a 
minor part of the total crop that is grown to produce them. Efficient use of the 
lignocellulosic biomass would add significant feedstock potential from the same 
agricultural area. Next to lignocellulosic biomass from food crops, there is also 
non-food biomass available that can be used as substrate. Examples are wood 
derived from forestry or energy crops such as switch grass or elephant grass. Use of 
feedstocks that can grow on marginal lands adds even more available feedstock and 
economic growth potential.
Lignocellulose is the dry-matter of plant biomass and contains the fermentable 
sugars stored as the sugar polymers cellulose and hemi-cellulose. Cellulose is a 
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glucose polymer and hemi-cellulose is a substituted xylose polymer. Extensive 
pretreatment is required to obtain fermentable sugars from these polymers and 
potential fermentation inhibitors are generated in the process. Enzymatic conversion 
is often part of this pretreatment. Biorefineries are the industrial sites where biomass 
is converted to fermentable sugars, and subsequently to green chemicals. At the 
moment there are four biorefineries operational for production of bioethanol from 
lignocellulosic subtrates. Two in the United States from DSM-Poet and DuPont, one 
in Brazil from GraalBio and one in Italy from M&G.
The ideal bacterial cell factory
The next question is which bacterium to use as bacterial cell factory? The ideal 
bacterial cell factory should have the potential to produce the target product at high 
productivities and yield (Gustavsson & Lee, 2016). Its substrate flexibility preferably 
allows for the use of sucrose, glucose, xylose and arabinose to allow for fermentation 
of lignocellulosic substrates. Its nutrient requirements should allow for cost-effective 
cultivation in minimal medium. Tolerance against inhibitors generated in the 
lignocellulose pretreatment would be a pro, as would be tolerance against high 
product titres. Preferably, the organism should be able to grow under anaerobic or, 
at least, micro-aerobic conditions, but not be too sensitive to oxygen exposure. In 
general, the organism should be stable, robust against fluctuations in process 
conditions and insensitive to phage infections or microbial contamination. If the 
production organism does not combine all of these aspects already, or if it does not 
produce the target product, genetic accessibility is a prerequisite to introduce those 
characteristics by metabolic engineering. No organism combines all desired 
characteristics. The ease of engineering and the broad knowledge on its physiology 
has made many choose for E. coli. Some other bacteria have reasonable engineering 
possibilities, but many lack efficient tools. Further development of genetic tools for 
these more recalcitrant organisms would liberalize the strain development field.
The strain development cycle
Bacterial cell factories are developed using iterative cycles of design, build, test, and 
learn. Preferably, the production organism of choice already contains many of the 
desired characteristics.
Design
The traits that are missing are defined in the design phase. These can be complete 
new pathways that need to be added (as described for the production of 
1,3-propanediol and 1,4-butanediol), elimination of pathways resulting in by-
products (as described for the production of d-lactic acid), or fine-tuning of 
expression levels of the bacteria’s own pathway genes. Genome-scale metabolic 
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models are instrumental in this step, in particular in subsequent cycles when the 
most obvious modifications have been applied and optimization targets are less 
obvious. 
Build
In the build phase the metabolic engineering is performed. The efficiency of the build 
phase depends on the genetic tools available. For E. coli high throughput strain 
engineering tools are available that allow to change many parts of the DNA in a 
single and relatively simple experiment. Most other bacteria lack such efficient tools, 
although tool development is catching up for quite a few. Two specific tools are 
worth mentioning for their importance in high-throughput strain construction: 
recombineering and CRISPR-Cas. Recombineering uses small synthetic DNA 
fragments to introduce the desired changes into the chromosome. These small 
fragments are introduced into the cells by transformation. Specific recombineering 
proteins, called beta or RecT, make sure that they are incorporated into the 
chromosome during DNA replication. More than one small DNA fragment can be 
introduced in parallel, a process called multiplexing, but only part of the population 
will obtain the modifications and these need to be selected for (Wang et al., 2009). 
The CRISPR-Cas technology can be used to enrich for the modified strains by cutting 
the chromosomes via targeting of the non-modified DNA sequences. Development of 
these recombineering and CRISPR-Cas tools for other bacteria will probably be 
crucial for efficient strain construction.
Design Build 
Test Learn 
Gene Selection 
HTS screening 
Recombineering 
Pathway Engineering 
CRISPR-Cas 
Parts Assembly 
Fermentation 
Proteomics/ 
Metabolomics 
Transcriptomics 
Modelling 
Bioinformatics 
Host selection 
Figure 5. The design-build-test-learn cycle of strain development.
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Test
The performance of the strains constructed in the build phase needs to be 
established in fermentations in the test phase. Preferably, transcriptomics, 
proteomics, and metabolomics studies are performed to get a better understanding 
of all effects that result from the modifications, including potential unwanted 
side-effects. As these experiments are laborious, time-consuming, and costly, a 
pre-selection of mutant strains needs to be performed. Often results from simple 
96-well plate assays are not sufficiently predictive to be useful. Several reporter 
systems have been developed that turn cells into fluorescent indicator strains for 
high productivity (Mahr & Frunzke, 2016; Yang et al, 2013). Still, the examples are 
all for titres that are well below industrially relevant ones, and it remains to be  
seen if the dynamic range of these biosensor systems can be stretched to be applied 
to select for improved strains at those high product concentrations. It is to be 
expected that the advances in microfluidics and microdroplet technologies will open 
up new avenues of high-throughput strain selection, including advanced mass 
spectrometry analytics and single-cell transcriptomics (Petzold et al., 2015; Kou et 
al., 2016). 
Learn
The fourth step in the cycle is the learn phase. This includes the bioinformatics 
analyses and interpretation of all data obtained in the test phase and feeding it into 
metabolic models to define next round’s targets.
Test Learn 
HTS screening Fermentation 
Proteomics/ 
Metabolomics 
Transcriptomics 
Modelling 
Bioinformatics 
Adaptive Laboratory Evolution 
Figure 6. Adaptive laboratory evolution cycle.
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Adaptive laboratory evolution
A complementary approach to the design and build phases is adaptive laboratory 
evolution. By repeated subculturing spontaneous mutations are selected for that 
result in improved growth. This can be used to develop increased resistance to high 
product concentrations or faster growth on a carbon source. The DNA sequences of 
the resulting strains can be compared to those of the parental strains to identify 
specific mutations responsible for the improved phenotype. This information can be 
fed back to the design phase.
So far, I have been setting the scene of the research field and illustrated several 
aspects relevant to developing bacterial cell factories. The last part of my lecture I 
will elaborate on my own work and plans for the near future.
Beyond E. coli
In my research I will focus on bacterial production of green chemicals, in particular 
of organic acids. These can be applied as purified products, like lactic acid or succinic 
acid, or can be converted into chemical derivatives including biopolymers, like 
poly-lactic acid. When trying to establish fermentations on lignocellulosic substrates, 
it seems logical to choose bacteria that naturally grow on plant waste. Thermophilic 
Gram-positives are such bacteria. This group of relatively unexplored thermophiles 
has many relevant characteristics that make them attractive as production organism 
for green chemicals. They produce various organic acids, have the ability to ferment  
a broad range of carbon sources and are suited for fermentation of lignocellulose-
derived substrates. Moreover, their thermophilic nature makes them particularly 
attractive for industrial processes by increased reaction rates, limited cooling costs 
and cooling times, and improved simultaneous saccharification and fermentation 
capacities. In the biorefinery concept first pretreatment steps are typically performed 
at temperatures well above 100°C. Subsequently, the fermentable sugars are released 
in the step called liquefaction or saccharification, which is performed at temperatures 
around 50 to 55°C. When using E. coli, the fermentor needs to be cooled down to 
Figure 7. Compost as a source for thermophilic bacilli.
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37°C, which requires energy and time. The use of a thermophile would eliminate 
such cooling step and also allow for simultaneous saccharification and fermentation, 
adding all to a more economic process. Therefore, my first research focus lies on 
isolating the right thermophiles and developing the genetic tools that allow for 
efficient metabolic engineering. That way all desired and complex characteristics, 
such as the thermophilic nature and the ability to make optimal use of lignocellulosic 
sugars, which cannot be easily transferred to E. coli, can be exploited and 
complemented with optimized organic acids production pathways.
My group is positioned in the Bacterial Genetics group at the Laboratory of 
Microbiology. The first studies in our lab were dedicated to isolating strains that 
make optimal use of plant sugars. For this, we looked at compost as isolation source. 
In compost plant biomass is partially decomposed by the activity of a complex 
microbial community. Therefore, compost is an ideal source for bacteria that are 
specialized in biomass degradation. Our first focus was on thermophiles that were 
able to use the main sugars that can be obtained from lignocellulosics. These are 
glucose from cellulose and xylose from hemicellulose. Elleke Bosma and Tom van de 
Weijer isolated a Bacillus smithii strain that was genetically accessible, could use 
xylose and glucose simultaneously, and produced lactic acid (Bosma et al., 2015a). 
Tools were developed to eliminate genes, which were applied for the construction of 
multiple knockouts (Bosma et al., 2015b). 
Having laid the fundaments for genetic engineering, we continued to improve our 
toolkit. Ioannis Mougiakos and Elleke Bosma have recently developed a method to 
apply Cas9 from Streptococcus pyogenes for genome editing of thermophiles 
Wild-type chromosome 
Modified chomosome 
 
Figure 8. Use of Cas9 as counterselection tool to target and eliminate 
wild-type sequences.
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(Mougiakos et al., 2017). As explained before, Cas9 can be used to simplify 
enrichment of mutants, as it can be applied to target and eliminate wild-type 
sequences. This drastically improves accuracy and speeds-up generation modified 
strains. Our approach makes use of the thermophilic nature of B. smithii, with 
optimal growth at 55°C, where Cas9 is inactive and recombination can take place, 
and its ability to grow at 37°C, where Cas9 will eliminate the unwanted wild-type 
cells. This trick turned out to be very successful. Having sufficient efficiency in the 
build phase, we now shift towards the next steps of the strain development cycle, 
while keeping an eye on continuous improvement.
 
Preferably, production strains would be able to directly use the hemicellulose and 
cellulose fractions of lignocellulose. Such strains would need only limited 
pretreatment of the biomass. In the biorefinery fermentable sugars are generated in a 
liquefaction step, in which enzymes are used to break-down the sugar polymers. 
Bacteria possessing hemicellulase or cellulase activity would not require such a step, 
or could do with less added enzymes, making the process more economic. Tijn Daas 
isolated thermophilic bacilli from compost that can consume the hemicellulose part 
of lignocellulose. He selected a genetically accessible Geobacillus thermodenitrificans 
strain that can make lactate from xylan (Daas et al., 2016). He also managed to 
introduce different type of cellulases, exo-glucanases and endoglucanases, into this 
strain. With this work he made the important first steps in developing an economic 
fermentation process from lignocellulosic substrates.
Succinate is an organic acid with great potential for production of biomaterials. 
Several microbial succinate production strains have been developed, some of which 
are being commercialized (Ahn et al., 2016). So far, no thermophilic production 
strains have been developed. Recently, two projects have been initiated in which 
Joyshree Ganguly and Jeroen Koendjbiharie try to set-up the strain development 
infrastructure to produce organic acids with anaerobic thermophilic clostridia. The 
species selected for this project is the only thermophile producing succinate as its 
main fermentation product. Although clostridia are known as notorious recalcitrant 
to genetic engineering and difficult to handle, the advanced tools developed in the 
other projects are expected to expedite successful engineering protocols. This would 
be a very important step forward in broadening the number of strains available for 
industrial strain development. 
Future directions
These are exciting times for biotechnologists. Advanced genetic engineering tools like 
recombineering and CRISPR-Cas are being developed for many organisms. 
Developments in robotics and automation allow high-throughput strain construction 
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in laboratories called biofoundries. At the same time microfluidic developments 
allow for miniaturization. Complete strain development processes can be combined 
on a single chip and whole laboratories are reduced to bench-top machines (Gach et 
al., 2016). Where E. coli used to be the common work-horse as bacterial cell factory, 
tool development for others is improving fast and the field is liberalizing. It cannot be 
expected that E. coli will be the one-size-fits-all solution to industrial fermentation. 
Several challenges still lie ahead of us. With high-throughput metabolic engineering 
tools quickly maturing, the screening phase will become limiting. Moreover, a better 
understanding of physiology and the function of hypothetical genes is still high on 
the agenda for many organisms. In particular, to improve the predictive power of 
metabolic models. A better insight in enzyme flexibility will also add to this. 
Adaptive laboratory evolution will be instrumental in developing growth-coupled 
complex traits. In addition, it will provide valuable information on the underlying 
mutations involved in the phenotypes. Through development of efficient design-
build-test-learn cycles for non-model organisms, such as thermophilic Gram-
positives, I intend to contribute to the field and, ultimately, contribute to a smooth 
transition to the biobased economy. 
Academic embedding and education
The university is a place for fundamental research and education. The strain 
development cycle required for successful development of bacterial cell factories 
involves many different disciplines that each have their specialization. As it would be 
impossible to master all aspects within one research group, collaborations between 
different groups within Wageningen University and Research and between our 
university and other universities and industries are essential. Current work already 
involves collaborations with colleagues from the chair groups Food Chemistry, Food 
Microbiology, and Systems and Synthetic Biology, while new collaborations will be 
initiated. National and international collaborations with other universities have been 
established and will be extended. For me the link with industry is a natural one and 
all projects have industrial support. 
The Wageningen University mission is to explore the potential of nature to improve 
the quality of life. This results in a strong focus on the biobased economy. 
Development of the biobased economy strongly depends on interactions between 
academia and industry. My position as special professor allows me to perform 
fundamental research at Wageningen University and translate the knowledge to the 
industrial practise. Next to that I am in a position where I can translate questions 
from industrial practise back to fundamental research questions that are relevant for 
the sector as a whole. Through my educational activities I can explain students about 
the importance of interactions between academia and industries. In collaboration 
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with colleagues from Microbiology, Biobased Chemistry and Technology and 
Bioprocess Engineering we are setting up a new course Advanced Biobased 
Conversion as part of the MicroMasters program Biobased Sciences for Sustainability 
and the master Biobased Sciences. In the master course Applied and Molecular 
Microbiology I teach the new generation of biotechnologists both the basics of and 
the latest developments in genome editing. To this end, the course is updated on a 
yearly basis. It is very rewarding to see that several taltented students continued with 
their master thesis in my group or decided to do an internship at Corbion.
Concluding remarks
I am coming to the end of this lecture. I have explained the relevance of bacterial cell 
factories in the biobased economy. Biobased feedstocks can be converted to green 
chemicals that can be used to produce materials such as bioplastics. Thermophiles 
have many advantages for application in biorefineries. Advances in efficient 
metabolic engineering and other tools are required to allow optimal execution of 
design-build-test-learn cycles of strain development. Adaptive laboratory evolution 
can be an attractive alternative for specific growth-coupled optimization processes. 
Through my research projects and teaching activities I aim to contribute to a 
transition from an petrol-based economy to a biobased economy.
Words of gratitude
My final words will be my words of gratitude. I would not have been able to get to this 
privileged position, without the support of many.
First of all, I would like to thank my parents for giving me the freedom to do the things I 
wanted to do and to give their unconditional support. My mother passed away in 1996 
in the middle of my PhD period. My father passed away at end of 2015, just before I got 
appointed. He was very involved with the process and would have been very proud to 
be here.
I would like to thank the former rector Martin Kropff and the current rector Arthur Mol 
for their confidence in me. Also thanks to Raoul Bino for his support to my appointment.
Special thanks goes to my mentor Willem de Vos. I admire your energy, speed of 
thinking (and talking), expertise, scientific leadership and managerial skills. We got to 
know each other when I did my master thesis at the Bacterial Genetics Group in the 
Laboratory of Microbiology in 1991. You became my promotor for the PhD project that I 
performed in your group at NIZO food research. And you seem to be involved in every 
major step I took afterwards. After eight years at NIZO, you alerted me on a position at 
Purac, now Corbion. This gave me the possibility to start-up my own strain development 
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group. And you were crucial in getting this Special Professorship organized. 
My time at NIZO was a very important one. The cellar was a cauldron of fun and 
science. It is amazing to see how many of my former direct colleagues made it to 
professor.
The process of becoming a special professor takes time. All the time, it was supported 
by my superiors from Purac and, later, Corbion. Therefore, I would like to thank 
Peter Jansen, Jan van Breugel, Rop Zoetemeyer, Tony Else, Heleen Goorissen, Sven 
Thormählen, Tjerk de Ruiter, and Marcel Wubbolts for their continuous support.
I would like to thank all my Corbion colleagues, particularly from the R&D 
Biotechnology department. I specifically want to mention my Strain Development 
team, who made an important contribution to my professional success. Here, I 
should mention Mariska van Hartskamp, who has a hand in nearly everything I do at 
Corbion. And even a hand in this lecture.
I have been a visiting scientist at the Laboratory of Microbiology from 2009 onwards.  
I would like to thank everyone for hosting me. It is a pleasure to see that we now 
have become real colleagues. Special thanks to the people from the Bacterial Genetics 
Group, and in particular John van der Oost. Being in close proximity to one of the 
godfathers of CRISPR-Cas research turned out to be very fruitful.
Needless to say that I want to thank the current and past Bacterial Cell Factories 
team. Elleke Bosma, Tom van de Weijer, Tijn Daas, Ioannis Mougiakos, Jeroen 
Koendjbiharie, Joyshree Ganguly and their students are the driving forces, hands and 
brains that make everything happen.
Ik wil mijn familie en vrienden bedanken voor hun steun en interesse.
Suzan, het is een genot om je te zien opgroeien. We lijken zeer op elkaar. Toch kan je 
me vaak een spiegel voorhouden en op jouw manier zaken relativeren.
Marja. Waar zou ik zonder jou zijn? Bedankt dat je er voor me bent. Bedankt voor je 
liefde, zorg  en steun voor al meer dan 26 jaar. Ik hoop dat we daar nog vele jaren aan 
toe mogen voegen.
Dear audience. Thank you for coming to Wageningen to attend this lecture.
Ik heb gezegd
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‘The research of Bacterial Cell Factories aims to apply bacteria for
production of biobased chemicals from renewable resources. The
focus lies on thermophilic Gram-positives. This group of relatively 
unexplored thermophiles has many relevant characteristics that 
make them attractive as production organism for green 
chemicals. Development of genetic tools is a requirement for 
high-throughput engineering. The scientific challenge lies in 
exploring and exploiting the microbial physiology of the selected 
production organisms, involving an integrated approach of 
various disciplines. Successful development of such Bacterial Cell 
Factories is crucial for establishing the biobased economy.’
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